Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 16 AL 30

Donepezil: an important prototype to the design of new drug candidates for Alzheimer's disease

Rodrigues Simões MC, Dias Viegas FP, Moreira MS, de Freitas Silva M, Riquiel MM, da Rosa PM, Castelli MR, dos Santos MH, Soares MG, Viegas C Jr.

Mini Rev Med Chem. 2014 Jan;14(1):2-19. doi: 10.2174/1389557513666131119201353.

A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease

Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP.

Curr Alzheimer Res. 2014 Jan;11(1):47-58. doi: 10.2174/1567205010666131212110148.

Systematic review of the effects of exercise on activities of daily living in people with Alzheimer's disease

Rao AK, Chou A, Bursley B, Smulofsky J, Jezequel J.

Am J Occup Ther. 2014 Jan-Feb;68(1):50-6. doi: 10.5014/ajot.2014.009035.

Vitamin E, memantine, and Alzheimer disease

Evans DA, Morris MC, Rajan KB.

JAMA. 2014 Jan 1;311(1):29-30. doi: 10.1001/jama.2013.282835.

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial

Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Zachariah S, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Segal Y, Peduzzi PN, Guarino PD.

JAMA. 2014 Jan 1;311(1):33-44. doi: 10.1001/jama.2013.282834.

Emerging therapeutics for Alzheimer's disease

Chiang K, Koo EH.

Annu Rev Pharmacol Toxicol. 2014;54:381-405. doi: 10.1146/annurev-pharmtox-011613-135932.

Omega-3 fatty acids: a growing ocean of choices

Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV.

Curr Atheroscler Rep. 2014 Feb;16(2):389. doi: 10.1007/s11883-013-0389-6.

Intranasal therapeutic strategies for management of Alzheimer's disease

Sood S, Jain K, Gowthamarajan K.

J Drug Target. 2014 May;22(4):279-94. doi: 10.3109/1061186X.2013.876644. Epub 2014 Jan 9.

Immunotherapy for Alzheimer's disease

Wisniewski T, Goñi F.

Biochem Pharmacol. 2014 Apr 15;88(4):499-507. doi: 10.1016/j.bcp.2013.12.020. Epub 2014 Jan 9.

The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications

Su Y, Wang Q, Wang C, Chan K, Sun Y, Kuang H.

J Ethnopharmacol. 2014 Mar 28;152(3):403-23. doi: 10.1016/j.jep.2013.12.053. Epub 2014 Jan 9.

Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease

Sharma A, Bemis M, Desilets AR.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):409-14. doi: 10.1177/1533317513518650. Epub 2014 Jan 9.

Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease

Marek GJ, Katz DA, Meier A, Greco N 4th, Zhang W, Liu W, Lenz RA.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S364-73. doi: 10.1016/j.jalz.2013.09.010. Epub 2014 Jan 10.

Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles

Iqbal K, Liu F, Gong CX.

Biochem Pharmacol. 2014 Apr 15;88(4):631-9. doi: 10.1016/j.bcp.2014.01.002. Epub 2014 Jan 10.

γ-Secretase modulators: current status and future directions

Hall A, Patel TR.

Prog Med Chem. 2014;53:101-45. doi: 10.1016/B978-0-444-63380-4.00003-2.

[Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]

Asai M, Shirotani K, Kondo T, Inoue H, Iwata N.

Nihon Yakurigaku Zasshi. 2014 Jan;143(1):23-6. doi: 10.1254/fpj.143.23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias